Inhibition of cough reflex sensitivity by diphenhydramine during acute viral respiratory tract infection

Peter Vytautas Dicpinigaitis, Sean Dhar, Amber Johnson, Yvonne Gayle, John Brew, Wilson Caparros-Wanderley

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Currently available over-the-counter cough remedies historically have been criticized for lack of scientific evidence supporting their efficacy. Although the first-generation antihistamine diphenhydramine is classified as an antitussive by the United States Food and Drug Administration, to the authors’ knowledge it has never been shown to inhibit cough reflex sensitivity in subjects with pathological cough. Objective: To evaluate the effect of diphenhydramine on cough reflex sensitivity. Setting: Montefiore Medical Center, an academic medical center in New York City. Methods: Twenty two subjects with acute viral upper respiratory tract infection (common cold) underwent cough reflex sensitivity measurement employing capsaicin challenge on 3 separate days, 2 h after ingesting single doses of study drug (to coincide with peak blood concentrations), administered in randomized, double-blind manner: a multicomponent syrup containing diphenhydramine (25 mg), phenylephrine (10 mg), in a natural cocoa formulation; dextromethorphan (30 mg) syrup; and, placebo syrup. The standard endpoint of cough challenge was used: concentration of capsaicin inducing ≥5 coughs (C5). Main outcome measure: Effect on cough reflex sensitivity (C5). Results: A significant difference (p = 0.0024) was established among groups, with pairwise analysis revealing a significant increase in mean log C5 (0.4 ± 0.55 (SD); p < 0.01) for the diphenhydramine-containing medication versus placebo, but not for dextromethorphan versus placebo. Conclusions: Our results provide the initial evidence of the ability of diphenhydramine to inhibit cough reflex sensitivity in subjects with acute pathological cough. Timing of cough reflex sensitivity measurement may not have allowed demonstration of maximal antitussive effect of dextromethorphan.

Original languageEnglish (US)
Pages (from-to)471-474
Number of pages4
JournalInternational Journal of Clinical Pharmacy
Volume37
Issue number3
DOIs
StatePublished - Jun 1 2015

Fingerprint

Diphenhydramine
Cough
Respiratory Tract Infections
Reflex
Dextromethorphan
Antitussive Agents
Capsaicin
Cocoa
Histamine Antagonists
Phenylephrine
Placebos
Blood
Demonstrations
Inhibition (Psychology)
Common Cold
Aptitude
United States Food and Drug Administration
Pharmaceutical Preparations
Outcome Assessment (Health Care)

Keywords

  • Antihistamine
  • Common cold
  • Cough
  • Cough reflex
  • Diphenhydramine

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmaceutical Science
  • Pharmacology
  • Toxicology
  • Pharmacy

Cite this

Inhibition of cough reflex sensitivity by diphenhydramine during acute viral respiratory tract infection. / Dicpinigaitis, Peter Vytautas; Dhar, Sean; Johnson, Amber; Gayle, Yvonne; Brew, John; Caparros-Wanderley, Wilson.

In: International Journal of Clinical Pharmacy, Vol. 37, No. 3, 01.06.2015, p. 471-474.

Research output: Contribution to journalArticle

Dicpinigaitis, Peter Vytautas ; Dhar, Sean ; Johnson, Amber ; Gayle, Yvonne ; Brew, John ; Caparros-Wanderley, Wilson. / Inhibition of cough reflex sensitivity by diphenhydramine during acute viral respiratory tract infection. In: International Journal of Clinical Pharmacy. 2015 ; Vol. 37, No. 3. pp. 471-474.
@article{c224b5bdf1b7410ca4be7c551fc35476,
title = "Inhibition of cough reflex sensitivity by diphenhydramine during acute viral respiratory tract infection",
abstract = "Background: Currently available over-the-counter cough remedies historically have been criticized for lack of scientific evidence supporting their efficacy. Although the first-generation antihistamine diphenhydramine is classified as an antitussive by the United States Food and Drug Administration, to the authors’ knowledge it has never been shown to inhibit cough reflex sensitivity in subjects with pathological cough. Objective: To evaluate the effect of diphenhydramine on cough reflex sensitivity. Setting: Montefiore Medical Center, an academic medical center in New York City. Methods: Twenty two subjects with acute viral upper respiratory tract infection (common cold) underwent cough reflex sensitivity measurement employing capsaicin challenge on 3 separate days, 2 h after ingesting single doses of study drug (to coincide with peak blood concentrations), administered in randomized, double-blind manner: a multicomponent syrup containing diphenhydramine (25 mg), phenylephrine (10 mg), in a natural cocoa formulation; dextromethorphan (30 mg) syrup; and, placebo syrup. The standard endpoint of cough challenge was used: concentration of capsaicin inducing ≥5 coughs (C5). Main outcome measure: Effect on cough reflex sensitivity (C5). Results: A significant difference (p = 0.0024) was established among groups, with pairwise analysis revealing a significant increase in mean log C5 (0.4 ± 0.55 (SD); p < 0.01) for the diphenhydramine-containing medication versus placebo, but not for dextromethorphan versus placebo. Conclusions: Our results provide the initial evidence of the ability of diphenhydramine to inhibit cough reflex sensitivity in subjects with acute pathological cough. Timing of cough reflex sensitivity measurement may not have allowed demonstration of maximal antitussive effect of dextromethorphan.",
keywords = "Antihistamine, Common cold, Cough, Cough reflex, Diphenhydramine",
author = "Dicpinigaitis, {Peter Vytautas} and Sean Dhar and Amber Johnson and Yvonne Gayle and John Brew and Wilson Caparros-Wanderley",
year = "2015",
month = "6",
day = "1",
doi = "10.1007/s11096-015-0081-8",
language = "English (US)",
volume = "37",
pages = "471--474",
journal = "International Journal of Clinical Pharmacy",
issn = "2210-7703",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Inhibition of cough reflex sensitivity by diphenhydramine during acute viral respiratory tract infection

AU - Dicpinigaitis, Peter Vytautas

AU - Dhar, Sean

AU - Johnson, Amber

AU - Gayle, Yvonne

AU - Brew, John

AU - Caparros-Wanderley, Wilson

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Background: Currently available over-the-counter cough remedies historically have been criticized for lack of scientific evidence supporting their efficacy. Although the first-generation antihistamine diphenhydramine is classified as an antitussive by the United States Food and Drug Administration, to the authors’ knowledge it has never been shown to inhibit cough reflex sensitivity in subjects with pathological cough. Objective: To evaluate the effect of diphenhydramine on cough reflex sensitivity. Setting: Montefiore Medical Center, an academic medical center in New York City. Methods: Twenty two subjects with acute viral upper respiratory tract infection (common cold) underwent cough reflex sensitivity measurement employing capsaicin challenge on 3 separate days, 2 h after ingesting single doses of study drug (to coincide with peak blood concentrations), administered in randomized, double-blind manner: a multicomponent syrup containing diphenhydramine (25 mg), phenylephrine (10 mg), in a natural cocoa formulation; dextromethorphan (30 mg) syrup; and, placebo syrup. The standard endpoint of cough challenge was used: concentration of capsaicin inducing ≥5 coughs (C5). Main outcome measure: Effect on cough reflex sensitivity (C5). Results: A significant difference (p = 0.0024) was established among groups, with pairwise analysis revealing a significant increase in mean log C5 (0.4 ± 0.55 (SD); p < 0.01) for the diphenhydramine-containing medication versus placebo, but not for dextromethorphan versus placebo. Conclusions: Our results provide the initial evidence of the ability of diphenhydramine to inhibit cough reflex sensitivity in subjects with acute pathological cough. Timing of cough reflex sensitivity measurement may not have allowed demonstration of maximal antitussive effect of dextromethorphan.

AB - Background: Currently available over-the-counter cough remedies historically have been criticized for lack of scientific evidence supporting their efficacy. Although the first-generation antihistamine diphenhydramine is classified as an antitussive by the United States Food and Drug Administration, to the authors’ knowledge it has never been shown to inhibit cough reflex sensitivity in subjects with pathological cough. Objective: To evaluate the effect of diphenhydramine on cough reflex sensitivity. Setting: Montefiore Medical Center, an academic medical center in New York City. Methods: Twenty two subjects with acute viral upper respiratory tract infection (common cold) underwent cough reflex sensitivity measurement employing capsaicin challenge on 3 separate days, 2 h after ingesting single doses of study drug (to coincide with peak blood concentrations), administered in randomized, double-blind manner: a multicomponent syrup containing diphenhydramine (25 mg), phenylephrine (10 mg), in a natural cocoa formulation; dextromethorphan (30 mg) syrup; and, placebo syrup. The standard endpoint of cough challenge was used: concentration of capsaicin inducing ≥5 coughs (C5). Main outcome measure: Effect on cough reflex sensitivity (C5). Results: A significant difference (p = 0.0024) was established among groups, with pairwise analysis revealing a significant increase in mean log C5 (0.4 ± 0.55 (SD); p < 0.01) for the diphenhydramine-containing medication versus placebo, but not for dextromethorphan versus placebo. Conclusions: Our results provide the initial evidence of the ability of diphenhydramine to inhibit cough reflex sensitivity in subjects with acute pathological cough. Timing of cough reflex sensitivity measurement may not have allowed demonstration of maximal antitussive effect of dextromethorphan.

KW - Antihistamine

KW - Common cold

KW - Cough

KW - Cough reflex

KW - Diphenhydramine

UR - http://www.scopus.com/inward/record.url?scp=84939979670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939979670&partnerID=8YFLogxK

U2 - 10.1007/s11096-015-0081-8

DO - 10.1007/s11096-015-0081-8

M3 - Article

C2 - 25673148

AN - SCOPUS:84939979670

VL - 37

SP - 471

EP - 474

JO - International Journal of Clinical Pharmacy

JF - International Journal of Clinical Pharmacy

SN - 2210-7703

IS - 3

ER -